| Date Filed | Type | Description |
| 08/26/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 296 shares
@ $3.7145, valued at
$1.1k
Granted 296 options to buy
@ $4.37, valued at
$1.3k
|
|
| 04/04/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 334 shares
@ $3.6295, valued at
$1.2k
Granted 334 options to buy
@ $4.27, valued at
$1.4k
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 320 shares
@ $3.791, valued at
$1.2k
Granted 320 options to buy
@ $4.46, valued at
$1.4k
|
|
| 02/02/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 4,170 shares
@ $3.9355, valued at
$16.4k
Granted 4,170 options to buy
@ $4.63, valued at
$19.3k
|
|
| 01/19/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 273 shares
@ $4.182, valued at
$1.1k
Granted 273 options to buy
@ $4.92, valued at
$1.3k
|
|
| 01/14/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 418,944 options to buy
@ $4.81, valued at
$2M
|
|
| 01/04/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 233 shares
@ $3.9185, valued at
$913
Granted 233 options to buy
@ $4.61, valued at
$1.1k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 336 shares
@ $3.4085, valued at
$1.1k
Granted 336 options to buy
@ $4.01, valued at
$1.3k
|
|
| 11/02/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 335 shares
@ $3.417, valued at
$1.1k
Granted 335 options to buy
@ $4.02, valued at
$1.3k
|
|
| 10/19/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 341 shares
@ $3.366, valued at
$1.1k
Granted 341 options to buy
@ $3.96, valued at
$1.4k
|
|
| 10/04/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 338 shares
@ $3.3915, valued at
$1.1k
Granted 338 options to buy
@ $3.99, valued at
$1.3k
|
|
| 09/17/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 338 shares
@ $3.3915, valued at
$1.1k
Granted 338 options to buy
@ $3.99, valued at
$1.3k
|
|
| 09/02/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 320 shares
@ $3.5785, valued at
$1.1k
Granted 320 options to buy
@ $4.21, valued at
$1.3k
|
|
| 08/03/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 374 shares
@ $3.0685, valued at
$1.1k
Granted 374 options to buy
@ $3.61, valued at
$1.4k
|
|
| 07/19/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 358 shares
@ $3.196, valued at
$1.1k
Granted 358 options to buy
@ $3.76, valued at
$1.3k
|
|
| 07/02/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 315 shares
@ $3.638, valued at
$1.1k
Granted 315 options to buy
@ $4.28, valued at
$1.3k
|
|
| 06/17/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 275 shares
@ $4.165, valued at
$1.1k
Granted 275 options to buy
@ $4.9, valued at
$1.3k
|
|
| 06/02/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 314 shares
@ $3.655, valued at
$1.1k
Granted 314 options to buy
@ $4.3, valued at
$1.4k
|
|
| 05/18/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 358 shares
@ $3.196, valued at
$1.1k
Granted 358 options to buy
@ $3.76, valued at
$1.3k
|
|
| 05/04/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 304 shares
@ $3.774, valued at
$1.1k
Granted 304 options to buy
@ $4.44, valued at
$1.3k
|
|
| 04/19/2021 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 322 shares
@ $3.553, valued at
$1.1k
Granted 322 options to buy
@ $4.18, valued at
$1.3k
|
|
| 12/14/2020 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 278,350 options to buy
@ $4.53, valued at
$1.3M
|
|
| 08/07/2020 |
3
| Edwards Larry G. (CEO) has filed a Form 3 on LA JOLLA PHARMACEUTICAL CO |
| 07/29/2020 |
4
| Edwards Larry G. (See Remarks) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 1,346 shares
@ $0
Disposed/sold 623 restricted stock units
@ $0
Disposed/sold 1,374 restricted stock units
@ $0
Disposed/sold 6,595 restricted stock units
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 640 options to buy
@ $0
Disposed/sold 2,025 options to buy
@ $0
Disposed/sold 1,875 options to buy
@ $0 |
|
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| Edwards Larry G. (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 4,277 shares
@ $0
Granted 2,058 shares
@ $0
Granted 2,509 shares
@ $0
Granted 45,000 restricted stock units
@ $0
Granted 150,000 restricted stock units
@ $0 |
|
| 04/04/2018 |
4
| Edwards Larry G. (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Granted 40,000 restricted stock units
@ $0 |
|
| 03/06/2018 |
3
| Edwards Larry G. (COO) has filed a Form 3 on TETRAPHASE PHARMACEUTICALS INC |